The global market for Lab Automation in Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lab Automation in Drug Discovery, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lab Automation in Drug Discovery by region & country, by Type, and by Application.
The Lab Automation in Drug Discovery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lab Automation in Drug Discovery.
Market Segmentation
By Company
Thermo Fisher Scientific
Beckman Coulter (Danaher)
Hudson Robotics
Becton, Dickinson and Company
Agilent Technologies
Siemens Healthineers
Tecan Group Ltd
PerkinElmer
Bio-Rad
Roche
Shimadzu Corporation
Aurora Biomed
Segment by Type:
Automated Liquid Handlers
Automated Plate Handlers
Robotic Arms
Automated Storage and Retrieval Systems
Others
Segment by Application
Hospitals and Private Labs
Biotech and Pharma
Academics and Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lab Automation in Drug Discovery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lab Automation in Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lab Automation in Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Lab Automation in Drug Discovery Product Introduction
1.2 Global Lab Automation in Drug Discovery Market Size Forecast
1.2.1 Global Lab Automation in Drug Discovery Sales Value (2019-2030)
1.2.2 Global Lab Automation in Drug Discovery Sales Volume (2019-2030)
1.2.3 Global Lab Automation in Drug Discovery Sales Price (2019-2030)
1.3 Lab Automation in Drug Discovery Market Trends & Drivers
1.3.1 Lab Automation in Drug Discovery Industry Trends
1.3.2 Lab Automation in Drug Discovery Market Drivers & Opportunity
1.3.3 Lab Automation in Drug Discovery Market Challenges
1.3.4 Lab Automation in Drug Discovery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lab Automation in Drug Discovery Players Revenue Ranking (2023)
2.2 Global Lab Automation in Drug Discovery Revenue by Company (2019-2024)
2.3 Global Lab Automation in Drug Discovery Players Sales Volume Ranking (2023)
2.4 Global Lab Automation in Drug Discovery Sales Volume by Company Players (2019-2024)
2.5 Global Lab Automation in Drug Discovery Average Price by Company (2019-2024)
2.6 Key Manufacturers Lab Automation in Drug Discovery Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lab Automation in Drug Discovery Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lab Automation in Drug Discovery
2.9 Lab Automation in Drug Discovery Market Competitive Analysis
2.9.1 Lab Automation in Drug Discovery Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lab Automation in Drug Discovery Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lab Automation in Drug Discovery as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Automated Liquid Handlers
3.1.2 Automated Plate Handlers
3.1.3 Robotic Arms
3.1.4 Automated Storage and Retrieval Systems
3.1.5 Others
3.2 Global Lab Automation in Drug Discovery Sales Value by Type
3.2.1 Global Lab Automation in Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lab Automation in Drug Discovery Sales Value, by Type (2019-2030)
3.2.3 Global Lab Automation in Drug Discovery Sales Value, by Type (%) (2019-2030)
3.3 Global Lab Automation in Drug Discovery Sales Volume by Type
3.3.1 Global Lab Automation in Drug Discovery Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lab Automation in Drug Discovery Sales Volume, by Type (2019-2030)
3.3.3 Global Lab Automation in Drug Discovery Sales Volume, by Type (%) (2019-2030)
3.4 Global Lab Automation in Drug Discovery Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Private Labs
4.1.2 Biotech and Pharma
4.1.3 Academics and Research Institutes
4.1.4 Others
4.2 Global Lab Automation in Drug Discovery Sales Value by Application
4.2.1 Global Lab Automation in Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lab Automation in Drug Discovery Sales Value, by Application (2019-2030)
4.2.3 Global Lab Automation in Drug Discovery Sales Value, by Application (%) (2019-2030)
4.3 Global Lab Automation in Drug Discovery Sales Volume by Application
4.3.1 Global Lab Automation in Drug Discovery Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lab Automation in Drug Discovery Sales Volume, by Application (2019-2030)
4.3.3 Global Lab Automation in Drug Discovery Sales Volume, by Application (%) (2019-2030)
4.4 Global Lab Automation in Drug Discovery Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lab Automation in Drug Discovery Sales Value by Region
5.1.1 Global Lab Automation in Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lab Automation in Drug Discovery Sales Value by Region (2019-2024)
5.1.3 Global Lab Automation in Drug Discovery Sales Value by Region (2025-2030)
5.1.4 Global Lab Automation in Drug Discovery Sales Value by Region (%), (2019-2030)
5.2 Global Lab Automation in Drug Discovery Sales Volume by Region
5.2.1 Global Lab Automation in Drug Discovery Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lab Automation in Drug Discovery Sales Volume by Region (2019-2024)
5.2.3 Global Lab Automation in Drug Discovery Sales Volume by Region (2025-2030)
5.2.4 Global Lab Automation in Drug Discovery Sales Volume by Region (%), (2019-2030)
5.3 Global Lab Automation in Drug Discovery Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lab Automation in Drug Discovery Sales Value, 2019-2030
5.4.2 North America Lab Automation in Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lab Automation in Drug Discovery Sales Value, 2019-2030
5.5.2 Europe Lab Automation in Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lab Automation in Drug Discovery Sales Value, 2019-2030
5.6.2 Asia Pacific Lab Automation in Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lab Automation in Drug Discovery Sales Value, 2019-2030
5.7.2 South America Lab Automation in Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lab Automation in Drug Discovery Sales Value, 2019-2030
5.8.2 Middle East & Africa Lab Automation in Drug Discovery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lab Automation in Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lab Automation in Drug Discovery Sales Value
6.2.1 Key Countries/Regions Lab Automation in Drug Discovery Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lab Automation in Drug Discovery Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lab Automation in Drug Discovery Sales Value, 2019-2030
6.3.2 United States Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lab Automation in Drug Discovery Sales Value, 2019-2030
6.4.2 Europe Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lab Automation in Drug Discovery Sales Value, 2019-2030
6.5.2 China Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lab Automation in Drug Discovery Sales Value, 2019-2030
6.6.2 Japan Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lab Automation in Drug Discovery Sales Value, 2019-2030
6.7.2 South Korea Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lab Automation in Drug Discovery Sales Value, 2019-2030
6.8.2 Southeast Asia Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lab Automation in Drug Discovery Sales Value, 2019-2030
6.9.2 India Lab Automation in Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lab Automation in Drug Discovery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Lab Automation in Drug Discovery Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Beckman Coulter (Danaher)
7.2.1 Beckman Coulter (Danaher) Company Information
7.2.2 Beckman Coulter (Danaher) Introduction and Business Overview
7.2.3 Beckman Coulter (Danaher) Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Beckman Coulter (Danaher) Lab Automation in Drug Discovery Product Offerings
7.2.5 Beckman Coulter (Danaher) Recent Development
7.3 Hudson Robotics
7.3.1 Hudson Robotics Company Information
7.3.2 Hudson Robotics Introduction and Business Overview
7.3.3 Hudson Robotics Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hudson Robotics Lab Automation in Drug Discovery Product Offerings
7.3.5 Hudson Robotics Recent Development
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Company Information
7.4.2 Becton, Dickinson and Company Introduction and Business Overview
7.4.3 Becton, Dickinson and Company Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Becton, Dickinson and Company Lab Automation in Drug Discovery Product Offerings
7.4.5 Becton, Dickinson and Company Recent Development
7.5 Agilent Technologies
7.5.1 Agilent Technologies Company Information
7.5.2 Agilent Technologies Introduction and Business Overview
7.5.3 Agilent Technologies Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Agilent Technologies Lab Automation in Drug Discovery Product Offerings
7.5.5 Agilent Technologies Recent Development
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Company Information
7.6.2 Siemens Healthineers Introduction and Business Overview
7.6.3 Siemens Healthineers Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Siemens Healthineers Lab Automation in Drug Discovery Product Offerings
7.6.5 Siemens Healthineers Recent Development
7.7 Tecan Group Ltd
7.7.1 Tecan Group Ltd Company Information
7.7.2 Tecan Group Ltd Introduction and Business Overview
7.7.3 Tecan Group Ltd Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Tecan Group Ltd Lab Automation in Drug Discovery Product Offerings
7.7.5 Tecan Group Ltd Recent Development
7.8 PerkinElmer
7.8.1 PerkinElmer Company Information
7.8.2 PerkinElmer Introduction and Business Overview
7.8.3 PerkinElmer Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.8.4 PerkinElmer Lab Automation in Drug Discovery Product Offerings
7.8.5 PerkinElmer Recent Development
7.9 Bio-Rad
7.9.1 Bio-Rad Company Information
7.9.2 Bio-Rad Introduction and Business Overview
7.9.3 Bio-Rad Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bio-Rad Lab Automation in Drug Discovery Product Offerings
7.9.5 Bio-Rad Recent Development
7.10 Roche
7.10.1 Roche Company Information
7.10.2 Roche Introduction and Business Overview
7.10.3 Roche Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Roche Lab Automation in Drug Discovery Product Offerings
7.10.5 Roche Recent Development
7.11 Shimadzu Corporation
7.11.1 Shimadzu Corporation Company Information
7.11.2 Shimadzu Corporation Introduction and Business Overview
7.11.3 Shimadzu Corporation Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shimadzu Corporation Lab Automation in Drug Discovery Product Offerings
7.11.5 Shimadzu Corporation Recent Development
7.12 Aurora Biomed
7.12.1 Aurora Biomed Company Information
7.12.2 Aurora Biomed Introduction and Business Overview
7.12.3 Aurora Biomed Lab Automation in Drug Discovery Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Aurora Biomed Lab Automation in Drug Discovery Product Offerings
7.12.5 Aurora Biomed Recent Development
8 Industry Chain Analysis
8.1 Lab Automation in Drug Discovery Industrial Chain
8.2 Lab Automation in Drug Discovery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lab Automation in Drug Discovery Sales Model
8.5.2 Sales Channel
8.5.3 Lab Automation in Drug Discovery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher Scientific
Beckman Coulter (Danaher)
Hudson Robotics
Becton, Dickinson and Company
Agilent Technologies
Siemens Healthineers
Tecan Group Ltd
PerkinElmer
Bio-Rad
Roche
Shimadzu Corporation
Aurora Biomed
听
听
*If Applicable.
